Sachs George, Scott David R, Wen Yi
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Curr Gastroenterol Rep. 2011 Dec;13(6):540-6. doi: 10.1007/s11894-011-0226-4.
Helicobacter pylori infects half of the world's population and plays a causal role in ulcer disease and gastric cancer. This pathogenic neutralophile uniquely colonizes the acidic gastric milieu through the process of acid acclimation. Acid acclimation is the ability of the organism to maintain periplasmic pH near neutrality in an acidic environment to prevent a fall in cytoplasmic pH in order to maintain viability and growth in acid. Recently, due to an increase in antibiotic resistance, the rate of H. pylori eradication has fallen below 80% generating renewed interest in novel eradication regimens and targets. In this article, we review the gastric biology of H. pylori and acid acclimation, various detection procedures, antibiotic resistance and the role that gastric acidity plays in the susceptibility of the organism to antibiotics currently in use and propose several novel drug targets that would promote eradication in the absence of antibiotics.
幽门螺杆菌感染了全球一半的人口,并在溃疡病和胃癌中起致病作用。这种致病性嗜中性菌通过酸适应过程独特地定殖于酸性胃环境中。酸适应是指生物体在酸性环境中维持周质pH接近中性,以防止细胞质pH下降,从而在酸性环境中维持生存能力和生长的能力。最近,由于抗生素耐药性增加,幽门螺杆菌根除率已降至80%以下,这引发了人们对新型根除方案和靶点的新兴趣。在本文中,我们综述了幽门螺杆菌的胃生物学特性和酸适应、各种检测方法、抗生素耐药性以及胃酸在该生物体对目前使用的抗生素易感性中所起的作用,并提出了几种新的药物靶点,这些靶点将在无抗生素的情况下促进根除。